Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
…, Z Zhang, WZ Kang, CQ Hao, K Dong, W Kang, JL Xia… - medrxiv, 2020 - medrxiv.org
Background SARS-CoV-2 is a novel human coronavirus, there is no specific antiviral drugs.
It has been proved that host-cell-expressed CD147 could bind spike protein of SARS-CoV-2 …
It has been proved that host-cell-expressed CD147 could bind spike protein of SARS-CoV-2 …
[HTML][HTML] Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
…, CQ Hao, J Wang, RH Xie, K Dong, JL Xia… - Signal transduction and …, 2021 - nature.com
Abstracts Recent evidence suggests that CD147 serves as a novel receptor for severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-…
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-…
Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score …
…, ZX Yin, CY He, RJ Li, KC Wu, JL Xia… - Journal of digestive …, 2013 - Wiley Online Library
Objective This prospective non‐randomized controlled trial aimed to compare the efficacy of
sorafenib in combination with transarterial chemoembolization ( TACE ) vs TACE alone for …
sorafenib in combination with transarterial chemoembolization ( TACE ) vs TACE alone for …
Epidemiology and preventive direction of periodontology in China
…, ZF Wu, YF Wu, R Shu, YP Pan, JL Xia - Journal of clinical …, 2007 - Wiley Online Library
Objective: The aim of this work was to estimate the present periodontal problems of people
in China, based on an epidemiological investigation of adults. Material and Methods: The …
in China, based on an epidemiological investigation of adults. Material and Methods: The …
Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children
…, L Wang, XF Zhang, YS Hu, YM Hu, JL Xia… - Expert review of …, 2016 - Taylor & Francis
Objectives: To evaluate the efficacy and immunogenicity of the Sinovac Enterovirus 71 (EV71)
vaccine for up to two years. Methods: We did a follow-up study of our initial randomized …
vaccine for up to two years. Methods: We did a follow-up study of our initial randomized …
[HTML][HTML] Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt
…, ZX Yin, JH Wang, WG Guo, J Niu, JL Xia… - World Journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To evaluate the effect of the shunting branch of the portal vein (PV)(left or right) and the
initial stent position (optimal or suboptimal) of a transjugular intrahepatic portosystemic …
initial stent position (optimal or suboptimal) of a transjugular intrahepatic portosystemic …
Spontaneous recovery of locomotion induced by remaining fibers after spinal cord transection in adult rats
…, BY Chen, HL Liu, B Lang, JL Xia… - Restorative …, 2003 - content.iospress.com
Purpose: A major issue in analysis of experimental results after spinal cord injury is spontaneous
functional recovery induced by remaining nerve fibers. The authors investigated the …
functional recovery induced by remaining nerve fibers. The authors investigated the …
Prevalence of dementia in China
L Liu, XE Guo, YQ Zhou, JL Xia - Dementia and geriatric cognitive …, 2003 - karger.com
To obtain prevalence estimates of dementia in China, an analysis of 17 studies published in
Chinese from 1990–1999 was carried out. The prevalence rates for the population aged 60 …
Chinese from 1990–1999 was carried out. The prevalence rates for the population aged 60 …
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial
YP Li, ZL Liang, JL Xia, JY Wu, L Wang… - The Journal of …, 2014 - academic.oup.com
Background. Vaccination is considered a top priority for the control of human enterovirus 71
(EV71) infection outbreaks. Methods. On the basis of phase I trial results, we conducted a …
(EV71) infection outbreaks. Methods. On the basis of phase I trial results, we conducted a …
Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months
…, YJ Zhang, L Chang, ZL Liang, JL Xia… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
The determination of lot-to-lot consistency in the manufacturing process is a mandatory step
in the clinical development of the novel enterovirus 71 (EV71) vaccine. A phase III, …
in the clinical development of the novel enterovirus 71 (EV71) vaccine. A phase III, …